Eli Lilly Long Term Debt 2010-2024 | LLY

Eli Lilly long term debt for the quarter ending September 30, 2024 was $29.045B, a 62.05% increase year-over-year.

  • Eli Lilly long term debt for 2023 was $18.321B, a 24.31% increase from 2022.
  • Eli Lilly long term debt for 2022 was $14.738B, a 3.97% decline from 2021.
  • Eli Lilly long term debt for 2021 was $15.346B, a 7.48% decline from 2020.

Eli Lilly Long Term Debt 2010-2024 | LLY

  • Eli Lilly long term debt for 2023 was $18.321B, a 24.31% increase from 2022.
  • Eli Lilly long term debt for 2022 was $14.738B, a 3.97% decline from 2021.
  • Eli Lilly long term debt for 2021 was $15.346B, a 7.48% decline from 2020.
Related Stocks
Company NameMarket
Cap
Novo Nordisk (NVO)$481.1B
Johnson & Johnson (JNJ)$374.3B
AbbVie (ABBV)$352.5B
Merck (MRK)$260.4B
Novartis AG (NVS)$217.6B
AstraZeneca (AZN)$200B
Pfizer (PFE)$151.4B
Sanofi (SNY)$130.2B
Innoviva (INVA)$1.3B